Ryder Steven bought YARW
October 29, 2026 · Form 4 insider transaction
Ryder Steven bought 113,137 shares of Yarrow Bioscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
113,137
Price
$0.00
Total value
N/A
InsiderRyder Steven
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 29, 2026
Filing dateOctober 30, 2026
Shares owned after113,137
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase 113,137 shares of the Issuer's common stock, one quarter of which will vest on July 28, 2027, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.